Docking and ADMET studies for investigating the anticancer potency of Moscatilin on APC10/DOC1 and PKM2 against five clinical drugs
Abstract Background Moscatilin is a bibenzyl derivative (stilbenoid), mainly found in Dendrobium species. This plant-derived chemical is a potential cytotoxic anticancer drug that acts against different cancer types. The present study compared the structural interactions of Moscatilin along with fiv...
Main Authors: | Ipsita Pujari, Ritobrata Sengupta, Vidhu Sankar Babu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-10-01
|
Series: | Journal of Genetic Engineering and Biotechnology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s43141-021-00256-6 |
Similar Items
-
Moscatilin suppresses the inflammation from macrophages and T cells
by: Zhang Ying, et al.
Published: (2022-04-01) -
Precocious in vitro flowering in threatened ornamental orchid, Dendrobium ovatum – Decoding the causal factors
by: Ipsita Pujari, et al.
Published: (2022-09-01) -
The expression of PKM1 and PKM2 in developing, benign, and cancerous prostatic tissues
by: Lin Li, et al.
Published: (2024-04-01) -
Dendrobium nobile Lindley and its bibenzyl component moscatilin are able to protect retinal cells from ischemia/hypoxia by dowregulating placental growth factor and upregulating Norrie disease protein
by: Wen-Haur Chao, et al.
Published: (2018-06-01) -
Revisiting glucose metabolism in cancer: lessons from a PKM knock-in model
by: Taku Sato, et al.
Published: (2018-07-01)